The antihypertensive effect of atenolol and bopindolol in the elderly

R. J. Viskoper, A. Laszt, S. Oren, Y. Hochberg, Y. Villa, I. Drexler, L. Bregman, J. Mishal

Research output: Contribution to journalArticlepeer-review

7 Scopus citations

Abstract

The antihypertensive efficacy and tolerability of two betablockers: atenolol and bopindolol, was compared in a group of 30 elderly subjects aged 64.8 ± 4.6 years. The daily dose of the two agents was relatively low. Atenolol 50-100 mg and bopindolol 0.5-1.0 mg sufficed to cause reduction of DBP to the target of </ 95 mm Hg, when applied as monotherapy. This was achieved in 75% of cases with bopindolol and in 93% of cases with atenolol. Atenolol, 50-100 mg/dd, lowered blood pressure from 173.7±13.2 103.7±3.0 (weekly) to 155.5±16.5 86.5±8.2 mm Hg (week 12) (P < 0.005) while bopindolol, 0.5-1.0 mg, lowered blood pressure from 171.6±11.3 104.1±3.6 to 158.7±20.9 86.1±6.0 mm Hg (P<0.005) Heart rate was reduced from 80.5 (week 4) to 66.7 ± 7.3 (week 12) by atenolol (P < 0.0001), and from 83.7 ± 11.8 (week 4) to 71.1 ± 7.5 (week 12) by bopindolol (P < 0.0001). Between treatment differences: comparisons yielded P values which were not sufficiently low to reject the null hypothesis of no difference between the two treatments. Well-being and short-term memory were not affected by either agent and tolerability of both drugs was good. These findings demonstrate that both bopindolol and atenolol are useful agents for control of hypertension in the elderly.

Original languageEnglish
Pages (from-to)185-186,187-191
JournalNetherlands Journal of Medicine
Volume35
Issue number4
StatePublished - 1 Oct 1989
Externally publishedYes

Keywords

  • Atenolol
  • Bopindolol
  • Elderly
  • Hypertension

Fingerprint

Dive into the research topics of 'The antihypertensive effect of atenolol and bopindolol in the elderly'. Together they form a unique fingerprint.

Cite this